Creating soluble forms of amyloid proteins linked to Alzheimer's disease
Patching Amyloid Surface onto Soluble Protein
This study is looking at how certain proteins related to Alzheimer's disease behave, with the hope of creating better ways to test new treatments and drugs that could help people with the condition.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10785633 on NIH RePORTER |
What this research studies
This research focuses on understanding the interactions of tau amyloid proteins, which are crucial in Alzheimer's disease and related dementias. By using advanced techniques, the researchers aim to recreate the specific three-dimensional structures of these proteins that are observed in patients. This approach will help in developing new methods for drug screening and treatment development, as traditional methods struggle with insoluble amyloids. The goal is to generate soluble forms of these proteins to facilitate better understanding and potential therapies for Alzheimer's disease.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or related dementias.
Not a fit: Patients with non-Alzheimer's related cognitive impairments or other unrelated neurological conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for Alzheimer's disease and related dementias by improving drug development processes.
How similar studies have performed: Other research has shown promise in using similar approaches to study amyloid proteins, indicating potential for success in this area.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Yang, Hyunjun — University of California, San Francisco
- Study coordinator: Yang, Hyunjun
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.